Docket Number:28T-1070122
Inventor:Kuo-Ping CHIU
IP Status:Trade Secret
Abstract:
A novel technology entitled ‘digital TOP-PCR’, which adopts TOP-PCR (T oligo-primed polymerase chain reaction), instead of regular PCR, for cell-free DNA (cfDNA) amplification. The feasibility is strongly supported by the fact that among all adaptor-dependent PCR methods essential for full-length amplification of unknown DNA sequences.
Fields of Application:
- The technology is used for clinical diagnosis.
- The technology is used for identification of disease-associated genomic mutations.
- The technology is used for prenatal genetic defects.
- The technology is used for microbial agents.
Advantages when compared to the existing technologies:
- Amplification of cfDNA requires adaptor-dependent PCR method like TOP-PCR.
- TOP-PCR possesses unprecedented efficiencies in both adaptor ligation and amplification.
- Digital TOP-PCR concerns the amplification of cfDNA, which remains available even if the diseased tissue is removed by surgery.
- Digital TOP-PCR is suitable for early detection of neoplasia.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you
